Key result
SAVR successfully treats post-TAVI prosthetic valve endocarditis in an 80-year-old high-risk patient.
Why the study?
Prosthetic valve endocarditis after TAVI or SAVR is a life-threatening complication requiring better understanding of its incidence, predictors, diagnosis, and management to improve outcomes.
Case Report (n=1)
Surgical aortic valve replacement can be successfully performed in high-risk patients presenting with prosthetic valve endocarditis after TAVI.
Supports SAVR feasibility in high-risk post-TAVI endocarditis; hypothesis-generating and should not yet change practice.
Prosthetic valve endocarditis (PVE) after transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement (SAVR) is a potential life threatening complication. Better understanding of the incidence, predictors, clinical presentation, diagnostic measures, complications and management of PVE may help improve TAVI long-term outcome. We report a case of TAVI-PVE in an 80-year-old high risk patient in whom SAVR was successfully performed. We have reviewed literature regarding TAVI-PVE.
No takes yet. Share an insight, caveat, or question.
Ahmad et al. (2016) conducted a case report in Prosthetic valve endocarditis after transcatheter aortic valve implantation (n=1). Surgical aortic valve replacement (SAVR) was evaluated. Surgical aortic valve replacement was successfully performed in an 80-year-old high-risk patient with prosthetic valve endocarditis after transcatheter aortic valve implantation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: